Global Opioids Market Size study & Forecast, by Product Type (Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Others), by Application (Pain Management, Cough Treatment, Diarrhea Treatment) and Regional Analysis, 2022-2029
Global Opioids Market is valued at approximately USD 22.66 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 1.2% over the forecast period 2022-2029. Opioids are medical agents that act on opioid receptors to cause morphine effects, which are used for pain relief, including anaesthesia. The market growth is driven by the factors such as increasing incidences of chronic pain among the population, a rise in consumption of these drugs to combat pain, coupled with the escalating geriatric population.
The rising number of product approval and the introduction of novel opioid medicines to cure patients suffering from chronic pain are acting as catalyzing factors for the growth of the market. For instance, in August 2020, Olinvyk (oliceridine) injection developed by Trevena, Inc., received Food and Drug Administration (FDA) approval. This new injection is developed to treat adults with acute pain that costs around USD 194 for a supply of 10 ml. Thereby, the rising launch of opioids-associated therapeutics with regulatory approvals is exhibiting a positive influence on market growth across the world. Moreover, growing investments in R&D activities, as well as the increasing healthcare expenditure are presenting various lucrative opportunities over the forecasting years. However, the execution of stringent government regulations for opioid prescription and the rise in opioid addiction (opioid crisis) is restricting the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Opioids Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the rising increasing approval of opioid-based medicines, along with the unmet medical needs. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the increasing number of initiatives undertaken by the government, as well as rising focus on providing high-quality opioids intended for pain management in the market space.
Major market players included in this report are:
Teva Pharmaceutical Industries Limited
Purdue Pharma LP
AstraZeneca Plc
C.H. Boehringer Sohn Ag and Co. Kg
Johnson & Johnson, Inc.
Sanofi S.A.
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals Inc.
Pfizer, Inc.
Sun Pharmaceuticals Industries Limited
Recent Developments in the Market:
In August 2022, Adalvo announced the acquisition of Onsolis a branded opioid product from a reputed U.S.-based specialty pharmacy company. The product is specially designed to indicate the management of chronic pain in cancer. The objective of this acquisition is to expand the company’s opioid product portfolio and present a high-growth opportunity for the company.
Global Opioids Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product Type, Application, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Methadone
Codeine
Fentanyl
Oxycodone
Morphine
Hydrocodone
Others
By Application:
Pain Management
Cough Treatment
Diarrhea Treatment
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
The rising number of product approval and the introduction of novel opioid medicines to cure patients suffering from chronic pain are acting as catalyzing factors for the growth of the market. For instance, in August 2020, Olinvyk (oliceridine) injection developed by Trevena, Inc., received Food and Drug Administration (FDA) approval. This new injection is developed to treat adults with acute pain that costs around USD 194 for a supply of 10 ml. Thereby, the rising launch of opioids-associated therapeutics with regulatory approvals is exhibiting a positive influence on market growth across the world. Moreover, growing investments in R&D activities, as well as the increasing healthcare expenditure are presenting various lucrative opportunities over the forecasting years. However, the execution of stringent government regulations for opioid prescription and the rise in opioid addiction (opioid crisis) is restricting the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Opioids Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the rising increasing approval of opioid-based medicines, along with the unmet medical needs. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the increasing number of initiatives undertaken by the government, as well as rising focus on providing high-quality opioids intended for pain management in the market space.
Major market players included in this report are:
Teva Pharmaceutical Industries Limited
Purdue Pharma LP
AstraZeneca Plc
C.H. Boehringer Sohn Ag and Co. Kg
Johnson & Johnson, Inc.
Sanofi S.A.
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals Inc.
Pfizer, Inc.
Sun Pharmaceuticals Industries Limited
Recent Developments in the Market:
In August 2022, Adalvo announced the acquisition of Onsolis a branded opioid product from a reputed U.S.-based specialty pharmacy company. The product is specially designed to indicate the management of chronic pain in cancer. The objective of this acquisition is to expand the company’s opioid product portfolio and present a high-growth opportunity for the company.
Global Opioids Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product Type, Application, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Methadone
Codeine
Fentanyl
Oxycodone
Morphine
Hydrocodone
Others
By Application:
Pain Management
Cough Treatment
Diarrhea Treatment
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Opioids Market, by Region, 2019-2029 (USD Billion)
1.2.2. Opioids Market, by Product Type, 2019-2029 (USD Billion)
1.2.3. Opioids Market, by Application, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL OPIOIDS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL OPIOIDS MARKET DYNAMICS
3.1. Opioids Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising number of product approval and the introduction of novel opioid medicines
3.1.1.2. Increasing incidences of chronic pains among the population
3.1.2. Market Challenges
3.1.2.1. Execution of stringent government regulations for opioid prescription
3.1.2.2. Rise in opioid addiction (opioid crisis)
3.1.3. Market Opportunities
3.1.3.1. Growing investments in R&D activities
3.1.3.2. Increasing healthcare expenditure
CHAPTER 4. GLOBAL OPIOIDS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL OPIOIDS MARKET, BY PRODUCT TYPE
6.1. Market Snapshot
6.2. Global Opioids Market by Product Type, Performance - Potential Analysis
6.3. Global Opioids Market Estimates & Forecasts by Product Type 2019-2029 (USD Billion)
6.4. Opioids Market, Sub Segment Analysis
6.4.1. Methadone
6.4.2. Codeine
6.4.3. Fentanyl
6.4.4. Oxycodone
6.4.5. Morphine
6.4.6. Hydrocodone
6.4.7. Others
CHAPTER 7. GLOBAL OPIOIDS MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Opioids Market by Application, Performance - Potential Analysis
7.3. Global Opioids Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. Opioids Market, Sub Segment Analysis
7.4.1. Pain Management
7.4.2. Cough Treatment
7.4.3. Diarrhea Treatment
CHAPTER 8. GLOBAL OPIOIDS MARKET, REGIONAL ANALYSIS
8.1. Opioids Market, Regional Market Snapshot
8.2. North America Opioids Market
8.2.1. U.S. Opioids Market
8.2.1.1. Product Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Opioids Market
8.3. Europe Opioids Market Snapshot
8.3.1. U.K. Opioids Market
8.3.2. Germany Opioids Market
8.3.3. France Opioids Market
8.3.4. Spain Opioids Market
8.3.5. Italy Opioids Market
8.3.6. Rest of Europe Opioids Market
8.4. Asia-Pacific Opioids Market Snapshot
8.4.1. China Opioids Market
8.4.2. India Opioids Market
8.4.3. Japan Opioids Market
8.4.4. Australia Opioids Market
8.4.5. South Korea Opioids Market
8.4.6. Rest of Asia Pacific Opioids Market
8.5. Latin America Opioids Market Snapshot
8.5.1. Brazil Opioids Market
8.5.2. Mexico Opioids Market
8.5.3. Rest of Latin America Opioids Market
8.6. Rest of The World Opioids Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Teva Pharmaceutical Industries Limited
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Purdue Pharma LP
9.2.3. AstraZeneca Plc
9.2.4. C.H. Boehringer Sohn Ag and Co. Kg
9.2.5. Johnson & Johnson, Inc.
9.2.6. Sanofi S.A.
9.2.7. Mallinckrodt Pharmaceuticals
9.2.8. Endo Pharmaceuticals Inc.
9.2.9. Pfizer, Inc.
9.2.10. Sun Pharmaceuticals Industries Limited
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Opioids Market, by Region, 2019-2029 (USD Billion)
1.2.2. Opioids Market, by Product Type, 2019-2029 (USD Billion)
1.2.3. Opioids Market, by Application, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL OPIOIDS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL OPIOIDS MARKET DYNAMICS
3.1. Opioids Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising number of product approval and the introduction of novel opioid medicines
3.1.1.2. Increasing incidences of chronic pains among the population
3.1.2. Market Challenges
3.1.2.1. Execution of stringent government regulations for opioid prescription
3.1.2.2. Rise in opioid addiction (opioid crisis)
3.1.3. Market Opportunities
3.1.3.1. Growing investments in R&D activities
3.1.3.2. Increasing healthcare expenditure
CHAPTER 4. GLOBAL OPIOIDS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL OPIOIDS MARKET, BY PRODUCT TYPE
6.1. Market Snapshot
6.2. Global Opioids Market by Product Type, Performance - Potential Analysis
6.3. Global Opioids Market Estimates & Forecasts by Product Type 2019-2029 (USD Billion)
6.4. Opioids Market, Sub Segment Analysis
6.4.1. Methadone
6.4.2. Codeine
6.4.3. Fentanyl
6.4.4. Oxycodone
6.4.5. Morphine
6.4.6. Hydrocodone
6.4.7. Others
CHAPTER 7. GLOBAL OPIOIDS MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Opioids Market by Application, Performance - Potential Analysis
7.3. Global Opioids Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. Opioids Market, Sub Segment Analysis
7.4.1. Pain Management
7.4.2. Cough Treatment
7.4.3. Diarrhea Treatment
CHAPTER 8. GLOBAL OPIOIDS MARKET, REGIONAL ANALYSIS
8.1. Opioids Market, Regional Market Snapshot
8.2. North America Opioids Market
8.2.1. U.S. Opioids Market
8.2.1.1. Product Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Opioids Market
8.3. Europe Opioids Market Snapshot
8.3.1. U.K. Opioids Market
8.3.2. Germany Opioids Market
8.3.3. France Opioids Market
8.3.4. Spain Opioids Market
8.3.5. Italy Opioids Market
8.3.6. Rest of Europe Opioids Market
8.4. Asia-Pacific Opioids Market Snapshot
8.4.1. China Opioids Market
8.4.2. India Opioids Market
8.4.3. Japan Opioids Market
8.4.4. Australia Opioids Market
8.4.5. South Korea Opioids Market
8.4.6. Rest of Asia Pacific Opioids Market
8.5. Latin America Opioids Market Snapshot
8.5.1. Brazil Opioids Market
8.5.2. Mexico Opioids Market
8.5.3. Rest of Latin America Opioids Market
8.6. Rest of The World Opioids Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Teva Pharmaceutical Industries Limited
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Purdue Pharma LP
9.2.3. AstraZeneca Plc
9.2.4. C.H. Boehringer Sohn Ag and Co. Kg
9.2.5. Johnson & Johnson, Inc.
9.2.6. Sanofi S.A.
9.2.7. Mallinckrodt Pharmaceuticals
9.2.8. Endo Pharmaceuticals Inc.
9.2.9. Pfizer, Inc.
9.2.10. Sun Pharmaceuticals Industries Limited
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Opioids Market, report scope
TABLE 2. Global Opioids Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Opioids Market estimates & forecasts by Product Type 2019-2029 (USD Billion)
TABLE 4. Global Opioids Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 5. Global Opioids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Opioids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Opioids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Opioids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Opioids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Opioids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Opioids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Opioids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Opioids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Opioids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Opioids Market
TABLE 70. List of primary sources, used in the study of global Opioids Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Opioids Market, report scope
TABLE 2. Global Opioids Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Opioids Market estimates & forecasts by Product Type 2019-2029 (USD Billion)
TABLE 4. Global Opioids Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 5. Global Opioids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Opioids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Opioids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Opioids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Opioids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Opioids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Opioids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Opioids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Opioids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Opioids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Opioids Market
TABLE 70. List of primary sources, used in the study of global Opioids Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Opioids Market, research methodology
FIG 2. Global Opioids Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Opioids Market, key trends 2021
FIG 5. Global Opioids Market, growth prospects 2022-2029
FIG 6. Global Opioids Market, porters 5 force model
FIG 7. Global Opioids Market, pest analysis
FIG 8. Global Opioids Market, value chain analysis
FIG 9. Global Opioids Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Opioids Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Opioids Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Opioids Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Opioids Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Opioids Market, regional snapshot 2019 & 2029
FIG 15. North America Opioids Market 2019 & 2029 (USD Billion)
FIG 16. Europe Opioids Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Opioids Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Opioids Market 2019 & 2029 (USD Billion)
FIG 19. Global Opioids Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Opioids Market, research methodology
FIG 2. Global Opioids Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Opioids Market, key trends 2021
FIG 5. Global Opioids Market, growth prospects 2022-2029
FIG 6. Global Opioids Market, porters 5 force model
FIG 7. Global Opioids Market, pest analysis
FIG 8. Global Opioids Market, value chain analysis
FIG 9. Global Opioids Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Opioids Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Opioids Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Opioids Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Opioids Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Opioids Market, regional snapshot 2019 & 2029
FIG 15. North America Opioids Market 2019 & 2029 (USD Billion)
FIG 16. Europe Opioids Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Opioids Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Opioids Market 2019 & 2029 (USD Billion)
FIG 19. Global Opioids Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
